FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Atopic Dermatitis
• Inflammatory Bowel Disease
• Osteoarthritis
• Psoriasis
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Methylprednisolone acetate (Methylprednisolone acetate)

Snippet

SUPPL AP for METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)